SCHEMBL10347754

SCHEMBL10347754

CC(C)=C(C)NC(=O)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
KDM4E B2RXH2 2/20 0.55
GAA P10253 2/20 0.55
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
GLA P06280 1/20 0.53
MAPT P10636 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
HDAC3 O15379 1/20 0.52
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
IDO1 P14902 1/20 0.52
ALOX15 P16050 1/20 0.52
HDAC1 Q13547 1/20 0.52
CA9 Q16790 1/20 0.52
HDAC7 Q8WUI4 1/20 0.52
HDAC2 Q92769 1/20 0.52
HSD17B10 Q99714 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19100020 0.82 ALDH1A1 (0.58) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL863064 0.82 ALDH1A1 (0.63) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL76489 0.81 ALDH1A1 (0.67) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL2159179 0.79 TDP1 (0.59) ALDH1A1KDM4EGAANPC1RAB9A
Hydrochloric Acid SCHEMBL27693713 0.79 ALDH1A1 (0.64) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL4585824 0.78 ALDH1A1 (0.64) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL13645595 0.78 ALDH1A1 (0.65) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL6551386 0.78 ALDH1A1 (0.55) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL3069836 0.78 ALDH1A1 (0.55) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL20198539 0.77 CYP1A2 (0.57) ALDH1A1NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180141952-A1 BICYCLIC HETEROCYCLIC COMPOUNDS AS PDE2 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2018-05-24 US disclosed
EP-0195201-B1 PROCESS FOR THE PREPARATION OF N-ACYL-2,3-DEHYDRO CARBOXYLIC ESTERS Degussa Aktiengesellschaft (DE) 1990-05-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141952-A1 BICYCLIC HETEROCYCLIC COMPOUNDS AS PDE2 INHIBITORS PDE2A, PDE12, PDE4D ALDH1A1 762/4885KDM4E 3056/4885GAA 230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.